Novavax faces high-stakes FDA review this week that will decide the fate of its Covid vaccine in the U.S.

Aqeel June 06, 2022 0

Novavax was part of the U.S. race to develop a vaccine in 2020, but the company faced manufacturing hurdles that delayed authorization.

from International: Top News And Analysis https://ift.tt/ouvLTCl

No comments

Subscribe to: Post Comments ( Atom )